Free tool
Stocks listed on ASX
We cover 13 companies listed on ASX. The median market value in the group is $8.27B. Across the group, the median move over the past trading day is +0.30%. Price change over the past year runs from −38.9% to +17.0% across the middle 80 percent of the group, with a median of −11.8%.
Other lists in this group
Table
13 of 1,792 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| RMD.AX | ResMed Inc. | $34.05B | Large cap | −24.75% |
| SIG.AX | Sigma Healthcare Limited | $21.65B | Large cap | −15.21% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| PME.AX | Pro Medicus Limited | $13.66B | Large cap | −39.15% |
| RHCPA.AX | Ramsay Health Care Limited | $10.16B | Large cap | +1.45% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| SHL.AX | Sonic Healthcare Limited | $7.14B | Mid cap | −11.84% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.79% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +4.88% |
| EBO.AX | EBOS Group Limited | $2.60B | Mid cap | −37.83% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +1.03% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.